HDBuzz – Page 42 – Huntington’s disease research news.

A Fault In The Supercomputer

February 19, 2026

Latest News

HDBuzz Prize winner 2012: Deep brain stimulation for HD

HDBuzz Prizewinner 2012: Deep brain stimulation to treat uncontrollable movements called chorea in Huntington's disea

October 29, 2012
Interview: Alice and Nancy Wexler

HDBuzz interviews Alice and Nancy Wexler, the sisters at the heart of the Hereditary Disease Foundation

October 20, 2012
Video: What’s new in Huntington's disease research 2012

Watch Ed Wild's address to the European Huntington's Association on how HD research works and the most promising poss

October 10, 2012
Shooting the messenger with single-stranded RNA gene silencing

New ‘single-stranded RNA’ gene silencing drugs could be safer & more effective to treat Huntington’s disease

September 24, 2012
EuroBuzz Video: Day 2

Watch the full video of EuroBuzz day 2 with Jeff Carroll and Ed Wild at the Euro-HD Network Meeting in Stockholm

September 21, 2012
EuroBuzz Video: Day 1

Watch the full video of EuroBuzz day 1 with Jeff Carroll and Ed Wild at the Euro-HD Network Meeting in Stockholm

September 19, 2012
EuroBuzz News: Day 3

EuroBuzz news: Day 3. Ed and Jeff reporting from the European Huntington’s Disease Network 2012 meeting in Stockholm

September 16, 2012
EuroBuzz News: Day 2

EuroBuzz news: Day 2. Ed and Jeff reporting from the European Huntington’s Disease Network 2012 meeting in Stockholm

September 15, 2012
EuroBuzz News: Day 1

EuroBuzz news: Day 1. Ed and Jeff reporting from the European Huntington’s Disease Network meeting in Stockholm

September 14, 2012
Coming Soon: EuroBuzz 2012

Coming soon from the Euro-HD Network Meeting in Stockholm: EuroBuzz!

September 10, 2012

HDBuzz Trial Tracker

Type A Meeting FDA to Define Next Steps for AMT-130

uniQure

Expected: mid-Feb 2026

Phase 3 for SOM3355 to commence

SOM Biotech

Expected: Q4 2026

Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02

Alnylam Pharmaceuticals

Expected: 2026

GENERATION-HD2 Trial Expected to Complete

Roche

Expected: 2026

Update on Planned Phase 2/3 Study for WVE-003

Wave Life Sciences

Expected: Not disclosed

Update on Phase 1/2a Clinical Data of VO659

Vico Therapeutics

Expected: Not disclosed

Additional insights from Phase 2 study results and update on plans for Phase 3 trial for votoplam

Novartis/PTC Therapeutics

Expected: Not disclosed

First participant in Phase 1/2 gene therapy trial dosed

Roche

Expected: Not disclosed

First participant dosed in POINT-HD trial

Roche

Expected: Not disclosed

Updates from the ongoing placebo-controlled Phase 2/3 FALCON-HD trial

Skyhawk Therapeutics

Expected: Not disclosed

Previously featured

Split Between Two Worlds: The Psychological Challenges for People at Risk of Huntington’s Disease

February 16, 2026
Putting it in print: oral drug branaplam lowered huntingtin, but safety concerns halted development

February 12, 2026
A hitch in the stitch reveals why DNA sequence patterns matter in Huntington’s disease

February 9, 2026
Worms to the Rescue: Separating the Good, the Bad, and the Clumpy Huntingtin

February 5, 2026
January 2026: This Month in Huntington’s Disease Research

February 2, 2026

More…

Start here

New to HD Research? Click here to get an overview

Follow HDBuzz

Suggest an article

Is there something you want us to write about? Tell us about it here. We consider all suggestions but can’t promise to write content about any particular suggestion.

Email editors@hdbuzz.net

A Fault In The Supercomputer

Latest News

HDBuzz Trial Tracker

Previously featured

Start here

Follow HDBuzz

Suggest an article